Clinical Trials Logo

Clinical Trial Summary

An actual use study to assess how men who respond to advertisements about urinary symptoms use tamsulosin in a simulated Over the Counter (OTC) setting including following "stop use and ask a doctor if" and "ask a doctor before use" statements and if they take the medication according to the label instructions, also assess any reported adverse events during simulated OTC use.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02573311
Study type Interventional
Source Boehringer Ingelheim
Contact
Status Completed
Phase Phase 3
Start date September 23, 2015
Completion date August 1, 2016

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05520151 - "Influence of Preoperative Immunomodulation by Oral Impact® on Postoperative Complications Following Cystectomies and Nephrectomies Phase 3
Recruiting NCT05989646 - Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children N/A
Recruiting NCT05250908 - INTIBIA Pivotal Study N/A
Completed NCT01340027 - A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder Phase 2
Completed NCT03099421 - Prostatic Artery Embolization for Benign Prostatic Obstruction N/A
Completed NCT03104907 - Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer N/A
Completed NCT02291432 - Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery Phase 1/Phase 2
Recruiting NCT05846555 - Optic Nerve Sheath Diameter in Urologic Surgery